Cannabis
destroys cancer cells
Researchers investigating the role of cannabis in cancer
therapy reveal it has the potential to destroy leukaemia
cells, in a paper published in the March 2006 edition of
Letters in Drug Design & Discovery.
Led by Dr Wai Man Liu, at Barts and the London, Queen
Mary's School of Medicine and Dentistry, the team has
followed up on their findings of 2005 which showed that
the main active ingredient in cannabis,
tetrahydrocannabinol, or THC, has the potential to be
used effectively against some forms of cancer. Dr Liu
has since moved to the Institute of Cancer in Sutton
where he continues his work into investigating the
potential therapeutic benefit of new anti-cancer agents.
It has previously been acknowledged that cannabis-based
medicines have merit in the treatment of cancer patients
as a painkiller; appetite stimulant and in reducing
nausea, but recently evidence has been growing of its
potential as an anti-tumour agent. The widely reported
psychoactive side effects and consequent legal status of
cannabis have, however, complicated its use in this
capacity. Although THC and its related compounds have
been shown to attack cancer cells by interfering with
important growth-processing pathways, it has not
hitherto been established exactly how this is achieved.
Now Dr Liu and his colleagues, using highly
sophisticated microarray technology - allowing them to
simultaneously detect changes in more than 18,000 genes
in cells treated with THC - have begun to uncover
further the existence of crucial processes through which
THC can kill cancer cells and potentially promote
survival.
Whilst leukaemia treatment is on the whole successful,
some people cannot be treated with conventional therapy
- 25 per cent of children with leukaemia fail to respond
to traditional treatment leaving their prognosis outcome
poor. Dr Liu's research findings provide a crucial first
step towards the development of new therapies that can
eradicate a deadly disease which affects millions of
children and adults worldwide.
Dr Liu said: "It is important to stress that these
cannabis-like substances are far removed from the
cannabis that is smoked. These novel compounds have been
specifically designed to be free of the psychoactive
features, whilst maintaining anti-cancer action.
Ultimately, understanding the fundamental mechanisms of
these compounds will provide us with insights into
developing new drugs that can be used to effectively
treat cancers."